 Connection
Yuki Fujiwara to Aged
This is a "connection" page, showing publications Yuki Fujiwara has written about Aged.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.140 |
|
|
|
-
Yamada H, Yamada R, Komohara Y, Pan C, Yoshii D, Yano H, Matsubara E, Shinchi Y, Tsukamoto H, Fujiwara Y, Ikeda K, Suzuki M. Integrative analysis of T cell subset-specific ICOS expression and tumor HLA class I/II expression in lung adenocarcinoma: implications for their interaction and clinical outcome. Cancer Immunol Immunother. 2026 Feb 28; 75(3).
Score: 0.014
-
Sakaida N, Yamada R, Arima K, Yamashita K, Hanada N, Yoshii D, Fujiwara Y, Nakashita C, Shimoda S, Iwatsuki M, Komohara Y. Relationship between nutritional indicators and clinicopathological factors, including immune cell densities in the tumor microenvironment, in patients with colorectal cancer. Med Mol Morphol. 2026 Jun; 59(2):113-123.
Score: 0.014
-
Ishida H, Rodriguez Franco S, Franklin O, Fujiwara Y, Khomiak A, Balmaceda NB, Pellegrini R, Mungo B, Schulick RD, Del Chiaro M. Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: A Comparative Study With Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2026 Mar; 33(3):2620-2631.
Score: 0.014
-
Tagayasu Y, Yamada R, Kanemitsu K, Kondo Y, Fujiwara Y, Tanizaki T, Itoyama R, Kitano Y, Hayashi H, Komohara Y, Iwatsuki M. Increased Infiltration of Tissue-Resident Memory T Cells Predicts a Good Response to Anti-PD-L1 Immunotherapy in Extrahepatic Cholangiocarcinoma. Pathobiology. 2026; 93(1):1-11.
Score: 0.014
-
Saisuwan K, Boonnate P, Goto H, Nakagawa R, Abe M, Hirabayashi K, Fujiwara Y, Kikuta K, Okada S. Establishment and characterization of TK-DDCS1: a novel IDH1 mutated dedifferentiated chondrosarcoma cell line. Hum Cell. 2025 Jun 03; 38(4):116.
Score: 0.014
-
Yamada R, Arima K, Yano H, Fujiwara Y, Yamashita K, Kanemitsu K, Hanada N, Yasunaga JI, Iwatsuki M, Mikami Y, Komohara Y. Impact of HTLV-1 infection on clinicopathological characteristics and tumour immune microenvironment in colorectal cancer. Virchows Arch. 2025 Oct; 487(4):853-863.
Score: 0.013
-
Ezaki A, Yano H, Pan C, Fujiwara Y, Anami T, Ibe Y, Ozaki Y, Nishizawa H, Motoshima T, Yatsuda J, Watanabe H, Maruyama T, Takeo T, Kamba T, Komohara Y. Immunohistochemical Analysis of a1-Acid Glycoprotein and Tumor Associated Macrophages in Clear Cell Renal Cell Carcinoma. Cancer Genomics Proteomics. 2025 Jan-Feb; 22(1):103-111.
Score: 0.013
-
Kanemitsu K, Yamada R, Pan C, Tsukamoto H, Yano H, Shiota T, Fujiwara Y, Miyamoto Y, Mikami Y, Baba H, Komohara Y. Age-associated reduction of sinus macrophages in human mesenteric lymph nodes. J Clin Exp Hematop. 2024 Jun 27; 64(2):79-85.
Score: 0.013
-
Matsubara E, Komohara Y, Shinchi Y, Mito R, Fujiwara Y, Ikeda K, Shima T, Shimoda M, Kanai Y, Sakagami T, Suzuki M. CD163-positive cancer cells are a predictor of a worse clinical course in lung adenocarcinoma. Pathol Int. 2021 Oct; 71(10):666-673.
Score: 0.010
-
Shiraishi D, Fujiwara Y, Horlad H, Saito Y, Iriki T, Tsuboki J, Cheng P, Nakagata N, Mizuta H, Bekki H, Nakashima Y, Oda Y, Takeya M, Komohara Y. CD163 Is Required for Protumoral Activation of Macrophages in Human and Murine Sarcoma. Cancer Res. 2018 06 15; 78(12):3255-3266.
Score: 0.008
-
Saito Y, Ohnishi K, Miyashita A, Nakahara S, Fujiwara Y, Horlad H, Motoshima T, Fukushima S, Jinnin M, Ihn H, Takeya M, Komohara Y. Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma. Cancer Immunol Res. 2015 Dec; 3(12):1356-63.
Score: 0.007
-
Komohara Y, Hasita H, Ohnishi K, Fujiwara Y, Suzu S, Eto M, Takeya M. Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer Sci. 2011 Jul; 102(7):1424-31.
Score: 0.005
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|